Our strategy was to build stepwise the N-1-hydroxypyrimidine base 8 since its direct synthesis by oxidation of the base has not yet been achieved. N-1-Hydroxyuracil 12 was selected as the key base in this series. 9 The preparation of this compound is described in Scheme 2. Treatment
